Logo

Aetna

Guardant Health Secures New Commercial Payor Coverage for Liquid Biopsy Cancer Profiling Test

With new coverage from Anthem Blue Cross and Blue Shield, Aetna, and Humana, the firm's Guardant360/Guardant360 CDx assay is now covered by all major commercial health insurers.

Aetna Updates Noninvasive Prenatal Testing Coverage Policy to Include All Pregnancies

Aetna's move comes at a time when a number of insurers including UnitedHealthcare have begun offering coverage of NIPT for average-risk pregnancies.

CVS Health, Tempus Precision Oncology Program Aims to Aid Oncologists, Improve Patient Outcomes
Premium

The CVS-Tempus partnership aims to streamline the cancer care process for patients from the point of prescribing onwards and connect patients with local trials.

Some Call for Expanded Payor Coverage of NIPS but Reluctance Remains
Premium

A preliminary analysis lends some support to covering NIPS for pregnancies beyond high-risk, and some payors have expanded coverage.  

 

Castle Biosciences Uveal Melanoma Prognostic Test Garners Coverage from Multiple Payors

The company announced positive coverage decisions from Palmetto GBA, 14 BCBS plans, and Aetna.

Feb 9, 2017

Aetna to Cover NxGen MDx Genetic Testing Services

Jan 4, 2017

GenomeWeb Index Falls 3 Percent in 2016; Genmark Leads Gainers as PacBio Drops

Dec 8, 2016

Aetna, Interpace Diagnostics Ink Coverage Agreement for Thyroid Assay

Jun 26, 2015

Veracyte Thyroid Cancer Test Added to Aetna's Laboratory Network

Jul 7, 2014

Aetna Begins Coverage of CardioDx's Coronary Artery Disease Test

Apr 4, 2014

Aetna Policy Bulletin Indicates Insurer Unlikely to Cover Most Proteomic Cancer Tests
Premium

Apr 2, 2014

MDx/CDx Focus: 23andMe Still Working with FDA; Aetna Lists Medically Necessary, Investigational Dx
Premium

May 9, 2013

NIH Funds USF, Aetna to Study BRCA Testing

Feb 7, 2013

Aetna Throws Support Behind Non-invasive Prenatal Tests for Down Syndrome

Mar 28, 2012

Abbott Challenges 'Incorrect Assumptions' in Cost-Effectiveness Study of Xalkori PGx Testing
Premium

Mar 21, 2012

Patient Enrichment to Limit PGx Testing for NSCLC Could Lower Costs, but Miss Responders
Premium

Jun 8, 2011

Anthem BCBS to Cover XDx's AlloMap in Stable Heart Transplant Patients
Premium

Mar 9, 2011

Aetna Deems XDx AlloMap Test 'Medically Necessary' for Monitoring Heart Transplant Patients
Premium

Mar 8, 2011

XDx's AlloMap Gets Positive Determination from Aetna

Sep 16, 2010

Aetna Funds BRCA Gene Test Study

Feb 10, 2010

Myriad Defends Policy of Urging Docs to Genetically Counsel BRACAnalysis Customers
Premium

Jan 13, 2010

Will Myriad's Marketing to Mammogram Centers Ease or Fan Over-Testing Concerns with BRACAnalysis?
Premium

Nov 4, 2009

Insurers Tracking Unnecessary Testing with Myriad's BRACAnalysis Tests
Premium

Jun 17, 2009

FDA Updates Plavix Label with PGx Data, but Does Not Provide Dosing Recommendations
Premium

May 5, 2009

CMS Rejects Medicare Payment for Genetic-Based Warfarin Dosing

Breaking News
The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.